⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5963506 | 0.70 | — | — | |
| SCHEMBL35355 | 0.70 | — | — | |
| SCHEMBL8377720 | 0.70 | — | — | |
| SCHEMBL8790967 | 0.70 | — | — | |
| SCHEMBL10423652 | 0.70 | — | — | |
| SCHEMBL21385228 | 0.70 | — | — | |
| SCHEMBL710129 | 0.70 | — | — | |
| SCHEMBL8377765 | 0.70 | PKM (0.51) | — | |
| SCHEMBL16632410 | 0.67 | L3MBTL1 (0.53) | — | |
| SCHEMBL21995599 | 0.67 | CRBN (0.66) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1524 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4677085-A1 | OLIGONUCLEOTIDE MODULATORS ACTIVATING FACTOR VII EXPRESSION AND USE THEREOF IN TREATMENT OF HEMOPHILIA | Ractigen Therapeutics (CN) | 2026-01-14 | — | — | EP | claimed |
| WO-2025201529-A1 | COMPOUNDS FOR SYNTHESIZING MODIFIED SMALL ACTIVATING RNA MOLECULES, MODIFIED SMALL ACTIVATING RNA MOLECULES AND USES THEREOF | RACTIGEN THERAPEUTICS (CN) | 2025-10-02 | — | — | WO | claimed |
| WO-2024183714-A1 | OLIGONUCLEOTIDE MODULATORS ACTIVATING FACTOR VII EXPRESSION AND USE THEREOF IN TREATMENT OF HEMOPHILIA | RACTIGEN THERAPEUTICS (CN) | 2024-09-12 | — | — | WO | claimed |
| CN-118546926-A | Oligonucleotide molecules and their use in tumor therapy | 中美瑞康核酸技术(南通)研究院有限公司 | 2024-08-27 | — | — | CN | claimed |
| CN-112912501-B | Oligonucleotide molecules and their use in tumor therapy | 中美瑞康核酸技术(南通)研究院有限公司 | 2024-07-16 | — | — | CN | claimed |
| CN-116848245-A | Double-stranded nucleic acid molecules for the treatment of proliferative vitreoretinopathy and uses thereof | 中美瑞康核酸技术(南通)研究院有限公司 | 2023-10-03 | — | — | CN | claimed |
| CN-116829716-A | Chemically modified small activating RNA | 中美瑞康核酸技术(南通)研究院有限公司 | 2023-09-29 | — | — | CN | claimed |
| CN-115916975-A | Nucleic acid molecules targeting MITF genes and uses thereof | 中美瑞康核酸技术(南通)研究院有限公司 | 2023-04-04 | — | — | CN | claimed |
| CN-114174511-A | Oligomeric nucleic acid molecule for activating ATOH1 gene and application thereof | 中美瑞康核酸技术(南通)研究院有限公司 | 2022-03-11 | — | — | CN | claimed |
| CN-110045048-B | HPLC-MSMS method for determining concentrations of two antitumor drugs in human plasma | 上海市第一人民医院 | 2021-07-06 | — | — | CN | claimed |
| WO-2008033432-A2 | IMMUNE MODULATION BY CHEMICALLY MODIFIED RIBONUCLEOSIDES AND OLIGORIBONUCLEOTIDES | COLEY PHARMACEUTICAL GROUP, INC. (US) | 2008-03-20 | — | — | WO | claimed |
| EP-1372659-B1 | SUBSTANCES FOR USE IN THERAPY OF DISEASES THAT ARE CAUSED BY HIGHLY PROLIFERATIVE CELLS | SCHMALZ HANS GUENTHER (DE) | 2004-07-28 | — | — | EP | claimed |
| US-20040116448-A1 | Substances for the therapy of diseases caused by highly proliferating cells | HANS-GUENTHER SCHMALZ (DE) | 2004-06-17 | — | — | US | claimed |
| US-20040092468-A1 | Immunostimulatory oligonucleotides with modified bases and methods of use thereof | SCHWARTZ DAVID (US) | 2004-05-13 | — | — | US | claimed |
| US-20040009602-A1 | DNA modifying molecules and methods of use thereof | THE GOVERNMENT OF THE U.S.A. AS REPRESENTED BY THE SECRETARY OF THE DEPT. OF HEALTH & HUMAN SERVICES | 2004-01-15 | — | — | US | claimed |
| EP-1121373-A2 | IMMUNOSTIMULATORY OLIGONUCLEOTIDES WITH MODIFIED BASES AND METHODS OF USE THEREOF | Dynavax Technologies Corporation (US) | 2001-08-08 | — | — | EP | claimed |
| WO-1999024621-A9 | METHODS AND COMPOSITIONS FOR DETECTION OF SPECIFIC NUCLEOTIDE SEQUENCES | CYGENE INC (US) | 2001-05-31 | — | — | WO | claimed |
| EP-1030936-A2 | METHODS AND COMPOSITIONS FOR DETECTION OF SPECIFIC NUCLEOTIDE SEQUENCES | Cygene, Inc. (US) | 2000-08-30 | — | — | EP | claimed |
| WO-1999062923-A2 | IMMUNOSTIMULATORY OLIGONUCLEOTIDES WITH MODIFIED BASES AND METHODS OF USE THEREOF | DYNAVAX TECHNOLOGIES CORPORATION (US) | 1999-12-09 | — | — | WO | claimed |
| WO-1999024621-A2 | METHODS AND COMPOSITIONS FOR DETECTION OF SPECIFIC NUCLEOTIDE SEQUENCES | CYGENE, INC. (US) | 1999-05-20 | — | — | WO | claimed |